skip to Main Content

Metformin May Improve Survival in Pancreatic Cancer Patients, Study Suggests

Newsfeed image, light gray text on dark gray background
Researchers from the Tisch Cancer Institute of the Icahn School of Medicine at Mount Sinai in New York City have found that patients with type 2 diabetes already taking metformin before a diagnosis of pancreatic cancer had better chance of survival than those on other medications.

The study findings, published in the American Journal of Gastroenterology, showed the benefits of metformin use before developing a very aggressive form of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC). Read more . . .

Back To Top